Literature DB >> 19362436

Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria.

R Artuso1, M A Mencarelli, R Polli, S Sartori, F Ariani, M Pollazzon, A Marozza, M R Cilio, N Specchio, F Vigevano, M Vecchi, C Boniver, B Dalla Bernardina, A Parmeggiani, S Buoni, G Hayek, F Mari, A Renieri, A Murgia.   

Abstract

BACKGROUND: Rett syndrome is a severe neurodevelopmental disorder affecting almost exclusively females. Among Rett clinical variants, the early-onset seizure variant describes girls with early onset epilepsy and it is caused by mutations in CDKL5.
METHODS: Four previously reported girls and five new cases with CDKL5 mutation, ranging from 14 months to 13 years, were evaluated by two clinical geneticists, classified using a severity score system based on the evaluation of 22 different clinical signs and compared with 128 classic Rett and 25 Zappella variant MECP2-mutated patients, evaluated by the same clinical geneticists. Clinical features were compared with previously described CDKL5 mutated patients. Both the statistical and the descriptive approach have been used to delineate clinical diagnostic criteria.
RESULTS: All girls present epilepsy with onset varying from 10 days to 3 months. Patients may present different type of seizures both at onset and during the whole course of the disease; multiple seizure types may also occur in the same individual. After treatment with antiepileptic drugs patients may experience a short seizure-free period but epilepsy progressively relapses. Typical stereotypic hand movements severely affecting the ability to grasp are present. Psychomotor development is severely impaired. In the majority of cases head circumference is within the normal range both at birth and at the time of clinical examination.
CONCLUSION: For the practical clinical approach we propose to use six necessary and eight supportive diagnostic criteria. Epilepsy with onset between the first week and 5 months of life, hand stereotypies, as well as severe hypotonia, are included among the necessary criteria. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362436     DOI: 10.1016/j.braindev.2009.02.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  26 in total

1.  Sequential Elution Interactome Analysis of the Mind Bomb 1 Ubiquitin Ligase Reveals a Novel Role in Dendritic Spine Outgrowth.

Authors:  Joseph Mertz; Haiyan Tan; Vishwajeeth Pagala; Bing Bai; Ping-Chung Chen; Yuxin Li; Ji-Hoon Cho; Timothy Shaw; Xusheng Wang; Junmin Peng
Journal:  Mol Cell Proteomics       Date:  2015-04-30       Impact factor: 5.911

2.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 3.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

4.  Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice.

Authors:  Elisa Frullanti; Sonia Amabile; Maria Grazia Lolli; Anna Bartolini; Gabriella Livide; Elisa Landucci; Francesca Mari; Flora M Vaccarino; Francesca Ariani; Luca Massimino; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

Review 5.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

6.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

7.  Rett syndrome: revised diagnostic criteria and nomenclature.

Authors:  Jeffrey L Neul; Walter E Kaufmann; Daniel G Glaze; John Christodoulou; Angus J Clarke; Nadia Bahi-Buisson; Helen Leonard; Mark E S Bailey; N Carolyn Schanen; Michele Zappella; Alessandra Renieri; Peter Huppke; Alan K Percy
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

8.  iPS cells to model CDKL5-related disorders.

Authors:  Mariangela Amenduni; Roberta De Filippis; Aaron Y L Cheung; Vittoria Disciglio; Maria Carmela Epistolato; Francesca Ariani; Francesca Mari; Maria Antonietta Mencarelli; Youssef Hayek; Alessandra Renieri; James Ellis; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2011-07-13       Impact factor: 4.246

9.  IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients.

Authors:  Giorgio Pini; Maria Flora Scusa; Laura Congiu; Alberto Benincasa; Paolina Morescalchi; Ilaria Bottiglioni; Pietro Di Marco; Paolo Borelli; Ubaldo Bonuccelli; Andrea Della-Chiesa; Adriele Prina-Mello; Daniela Tropea
Journal:  Autism Res Treat       Date:  2012-06-13

10.  GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.

Authors:  Gabriella Livide; Tommaso Patriarchi; Mariangela Amenduni; Sonia Amabile; Dag Yasui; Eleonora Calcagno; Caterina Lo Rizzo; Giulia De Falco; Cristina Ulivieri; Francesca Ariani; Francesca Mari; Maria Antonietta Mencarelli; Johannes Wilhelm Hell; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2014-06-11       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.